Maharashtra FDA Launches Special Drive to Inspect Liquid Oral Formulations
- byDoctor News Daily Team
- 10 October, 2025
- 0 Comments
- 0 Mins

Mumbai:In the wake of the death of 20 children in Madhya Pradesh linked to a contaminated cough syrup, the Maharashtra FDA has launched a special drive to inspect and test liquid oral formulations stocked by hospitals and distributors. The Food and Drug Administration (FDA) directed all joint commissioners and drug inspectors to immediately submit details of all manufacturers in their jurisdictions and to collect samples from government and semi-government hospitals, private wholesalers, and retailers. A circular was issued after a video conference chaired by the FDA commissioner on Tuesday. Also Read: Inside Coldrif Scandal: Tamil Nadu Plant Used Paint-Grade Chemicals, Violated 300+ Drug Norms Officials were directed to immediately report details of all liquid oral formulation manufacturers and ensure suspected batches are recalled from hospitals and distributors. Drug inspectors and assistant commissioners have been asked to collect samples from government and semi-government hospitals, as well as private wholesalers and retailers, for priority testing, the circular said. Samples from Mumbai, Konkan, Pune, and Nashik divisions will be sent to a laboratory in Mumbai, while those from Chhatrapati Sambhajinagar, Amravati, and Nagpur divisions will go to the Chhatrapati Sambhajinagar laboratory. Sampling is to be completed by October 9, with daily reports submitted via a dedicated Google Form. The inspections of all liquid oral manufacturers will be conducted from October 10 to 15 to verify the quality of solvents such as glycerin, sorbitol, and propylene glycol, confirm vendor validation, check testing protocols for DEG and EG, and ensure proper record-keeping, according to the circular. The FDA warned that manufacturers using suspect solvents or adulterated products will face stringent legal action. The campaign aims to enforce strict quality control and prevent recurrence of such incidents in the state. On Monday, the FDA in Maharashtra appealed to the public and chemists to immediately stop the sale or use of Coldrif Syrup, urging immediate reporting to the nearest Drugs Control Authority. Five children from Madhya Pradesh are in a critical condition, while 20 have died due to kidney infections caused by the consumption of the "contaminated" cough syrup, containing toxic substances like Diethylene Glycol and Ethylene Glycol. Also Read: 3 cough syrups recalled, none exported: CDSCO responds to WHO
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Mumbai's GT Hospital doctor injured after ceiling...
- 20 October, 2025
Rajasthan HC Quashes Ban on New B.Pharm Colleges,...
- 20 October, 2025
Dr. Reddy's Labs Gets CDSCO Panel Nod to Manufactu...
- 20 October, 2025
CDSCO Panel Rejects Pure and Cure's Empagliflozin-...
- 20 October, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!